magrolimab: Clinical Trials

3 trials of magrolimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 3

Follow magrolimab: new trials by email Literature Review of magrolimab trials Research Report on magrolimab

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia
Magrolimab, Venetoclax, Azacitidine - Acute Myeloid Leukemia
Phase 3TerminatedGilead Sciences3782022-07-072025-04-04
Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated
Magrolimab, Venetoclax, Azacitidine - Acute Myeloid Leukemia
Phase 3TerminatedGilead Sciences2582021-07-012025-02-05
Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS)
Magrolimab, Azacitidine, Placebo - Myelodysplastic Syndromes
Phase 3TerminatedGilead Sciences5392020-09-092024-06-27

Conditions studied

Leukemia, Myeloid, Acute (2)  ·  Myelodysplastic Syndromes (1)

Sponsors

Gilead Sciences (3)

Countries

Australia (3)  ·  Austria (3)  ·  Belgium (3)  ·  Canada (3)  ·  France (3)  ·  Germany (3)  ·  Hong Kong (3)  ·  Italy (3)  ·  Spain (3)  ·  Switzerland (3)  ·  United Kingdom (3)  ·  United States (3)  ·  Czechia (2)  ·  Hungary (2)  ·  Netherlands (2)

Results publications

PMID 37703506, PMID 36888930, PMID 40009500, PMID 40233321, PMID 42441929